The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis. Kretzschmar B, Pellkofer H, Weber MS Curr Neurol Neurosci Rep. 2016 Apr; 16(4):38. PMID: 26944956. Abstract CommentRecommendBookmarkWatch